NEK2 (NIMA related kinase 2)

2006-10-01  

Identity

HGNC
LOCATION
1q32.3
LOCUSID
ALIAS
HsPK21,NEK2A,NLK1,PPP1R111,RP67
FUSION GENES

Other Information

Locus ID:

NCBI: 4751
MIM: 604043
HGNC: 7745
Ensembl: ENSG00000117650

Variants:

dbSNP: 4751
ClinVar: 4751
TCGA: ENSG00000117650
COSMIC: NEK2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000117650ENST00000366998P51955
ENSG00000117650ENST00000366999P51955
ENSG00000117650ENST00000540251F6U4U2

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Organelle biogenesis and maintenanceREACTOMER-HSA-1852241
Cilium AssemblyREACTOMER-HSA-5617833
Anchoring of the basal body to the plasma membraneREACTOMER-HSA-5620912
Cell CycleREACTOMER-HSA-1640170
Cell Cycle, MitoticREACTOMER-HSA-69278
Mitotic G2-G2/M phasesREACTOMER-HSA-453274
G2/M TransitionREACTOMER-HSA-69275
Regulation of PLK1 Activity at G2/M TransitionREACTOMER-HSA-2565942
Centrosome maturationREACTOMER-HSA-380287
Recruitment of mitotic centrosome proteins and complexesREACTOMER-HSA-380270
Loss of proteins required for interphase microtubule organization from the centrosomeREACTOMER-HSA-380284
Loss of Nlp from mitotic centrosomesREACTOMER-HSA-380259
Regulation of mitotic cell cycleREACTOMER-HSA-453276
APC/C-mediated degradation of cell cycle proteinsREACTOMER-HSA-174143
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteinsREACTOMER-HSA-176814
APC/C:Cdc20 mediated degradation of mitotic proteinsREACTOMER-HSA-176409
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpointREACTOMER-HSA-179419
APC-Cdc20 mediated degradation of Nek2AREACTOMER-HSA-179409
AURKA Activation by TPX2REACTOMER-HSA-8854518

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
381828982024Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.0
384931502024Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.0
387218122024Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR-486-5p/NEK2 axis.0
387642962024NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells.0
387951322024NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1.0
381828982024Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.0
384931502024Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.0
387218122024Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR-486-5p/NEK2 axis.0
387642962024NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells.0
387951322024NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1.0
363709992023NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis.1
367386742023Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer.2
384949742023[Expression and clinical significance of NEK2 and EMT related molecules in oral squamous cell carcinoma].0
363709992023NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis.1
367386742023Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer.2

Citation

Dessen P

NEK2 (NIMA related kinase 2)

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43372/nek2